Le Lézard
Classified in: Health
Subject: SVY

Endoluminal Suturing Devices Market Size Worth $103.8 Million by 2027: Grand View Research, Inc.


SAN FRANCISCO, July 8, 2020 /PRNewswire/ -- The global endoluminal suturing devices market size is expected to reach USD 103.8 million by 2027, registering a CAGR of 12.0% over the forecast period, according to a new report by Grand View Research, Inc. The rapid growth can be attributed to factors such as increasing incidence of obesity and rising number of minimally invasive surgery.

Grand View Research Logo

According to the World Health Organization (WHO), in 2016, more than 1.9 billion people aged 18 and above were overweight, out of which over 650.0 million people were obese. Furthermore, rising awareness about personal care and the availability of various weight reduction techniques will boost the market during the forecast period.

Key suggestions from the report:

Read 110 page research report with ToC on "Endoluminal Suturing Devices Market Size, Share & Trends Analysis Report By Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery), By End Use, By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/endoluminal-suturing-devices-market

Technological advancement and the high adoption rate of endoluminal suturing devices are expected to boost market growth. In addition, the integration of robot-assisted surgery modalities in the field of gastroenterology is expected to expand the application of endoluminal procedures with high precision and reduced error. The robotic suturing technique gives surgeons a degree of freedom of robotic arm and also provide three-dimensional vision. Thus, the availability of these advance techniques is allowing doctors and surgeons to explore various applications of endoluminal surgeries. However, endoluminal suturing devices are comparatively new to the market. Only a handful of companies are making these medical devices and many new players are in a process of FDA approvals and clinical trials.

Grand View Research has segmented the global endoluminal suturing devices market on the basis of application, end use, and region:

    Find more research reports on Medical Devices Industry, by Grand View Research:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected] 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg  

 


These press releases may also interest you

at 23:03
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

at 22:29
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 21:30
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...



News published on and distributed by: